Cite
Tumor Microenvironment-Activable Manganese-Boosted Catalytic Immunotherapy Combined with PD-1 Checkpoint Blockade
MLA
Zhiyu Zhao, et al. “Tumor Microenvironment-Activable Manganese-Boosted Catalytic Immunotherapy Combined with PD-1 Checkpoint Blockade.” ACS Nano, vol. 16, no. 12, Nov. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f2ce1e894714df57cc676725822635fe&authtype=sso&custid=ns315887.
APA
Zhiyu Zhao, Shuming Dong, Yue Liu, Jianxin Wang, Li Ba, Cong Zhang, Xinyu Cao, Changjun Wu, & Piaoping Yang. (2022). Tumor Microenvironment-Activable Manganese-Boosted Catalytic Immunotherapy Combined with PD-1 Checkpoint Blockade. ACS Nano, 16(12).
Chicago
Zhiyu Zhao, Shuming Dong, Yue Liu, Jianxin Wang, Li Ba, Cong Zhang, Xinyu Cao, Changjun Wu, and Piaoping Yang. 2022. “Tumor Microenvironment-Activable Manganese-Boosted Catalytic Immunotherapy Combined with PD-1 Checkpoint Blockade.” ACS Nano 16 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f2ce1e894714df57cc676725822635fe&authtype=sso&custid=ns315887.